GlassScriptPhysician profile
Roslyn V Mallory
NPI 1871771410
$2,105.14
in general payments reported to CMS, 2019-2025
24 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $254 · 2021: $324 · 2022: $596 · 2023: $287 · 2024: $224 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $396.31 | 2019-2025 | |
| Coloplast Corp | $313.50 | 2020-2022 | |
| Pfizer INC. | $189.56 | 2019-2023 | |
| Therapeuticsmd, INC. | $154.72 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $154.07 | 2022 | |
| Astellas Pharma US INC | $144.43 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $136.92 | 2019-2025 | Slynd |
| Roche Diagnostics Corporation | $104.92 | 2019 | |
| Organon LLC | $93.10 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $71.94 | 2019-2023 | |
| Myovant Sciences INC. | $54.23 | 2021-2022 | |
| Intuitive Surgical, INC. | $52.47 | 2020 | |
| Aspira Women'S Health INC | $37.36 | 2021 | |
| Agile Therapeutics, INC. | $30.66 | 2021-2023 | Twirla |
| Amag Pharmaceuticals, INC. | $28.06 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $26.15 | 2019-2022 | |
| Sage Therapeutics, LLC | $21.73 | 2025 | Zurzuvae |
| Millicent US INC | $21.45 | 2024 | Intrarosa, Femring |
| Axonics, INC. | $18.41 | 2023 | Axonics |
| Duchesnay USA Incorporated | $18.23 | 2019 | |
| Avion Pharmaceuticals | $12.62 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.50 | 2021 | |
| Merck Sharp & Dohme LLC | $11.80 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roslyn Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.